EoE: Not just an elimination diet, for an elimination diet that works

Published Date: 08 Mar 2023

Eliminating milk alone not only reduces the symptoms of patients with eosinophilic esophagitis, but also improves quality of life.

Read Full News

Latest News

Hyponatremia in Man Reveals Isolated Aldosterone Deficiency

Persistent hyponatremia despite treatment prompts further evaluation, revealing isolated aldosterone deficiency despite normal adrenal function and leading to effective therapy.

How to Spot Anxiety in General Practice

Anxiety disorders are common but often missed in primary care, and routine screening, cognitive-behavioral therapy, and collaborative care may help GPs identify and manage them earlier.

Australia Seeks to Reverse Surge in Syphilis Cases

Syphilis has reemerged as a major public health threat across Australia but signs indicate that things might be improving.

Why This Painful Disorder Can Take a Decade-Plus to Diagnose

A connective tissue disorder with wide-ranging symptoms, hypermobile Ehlers-Danlos syndrome can lead to serious complications and harm from a medical system that doesn’t understand it.

Finding the Mystery to Trigger-Induced Atrial Fibrillation

An effort to produce recommendations for hospitalists to treat atrial fibrillation led to a wide-ranging search for answers.

Getting Blood Into Ambulances Matters in Trauma Cases

More hospitals and EMS systems are stocking blood to begin transfusions in trauma patients. Many believe it is saving lives.

Todays Updates

Body Clock Genes Tied to Prostate Radiotherapy Toxicity

Could timing prostate cancer radiotherapy according to patients’ circadian rhythm genes reduce the risk for late side effects?

Gedatolisib Combo Approved for Advanced Breast Cancer

Progression-free survival with the multitarget PAM inhibitor approaches 10 months after anti-CDK4/6 and aromatase inhibitor failure.

MGRS Relapse-Free Survival Better With Maintenance Therapy

Researchers retrospectively analyzed outcomes for 50 patients with biopsy-proven monoclonal gammopathy of renal significance for a median follow-up of 6.15 years.

Lung Transplant for Lung Cancer: Promising, in Rare Cases

In a small single-center study, 1-year survival is 100% among carefully selected patients who undergo bilateral lung transplantation for stage IV disease confined to the lungs.

Todays Updates

Body Clock Genes Tied to Prostate Radiotherapy Toxicity

Could timing prostate cancer radiotherapy according to patients’ circadian rhythm genes reduce the risk for late side effects?

Gedatolisib Combo Approved for Advanced Breast Cancer

Progression-free survival with the multitarget PAM inhibitor approaches 10 months after anti-CDK4/6 and aromatase inhibitor failure.

MGRS Relapse-Free Survival Better With Maintenance Therapy

Researchers retrospectively analyzed outcomes for 50 patients with biopsy-proven monoclonal gammopathy of renal significance for a median follow-up of 6.15 years.

Lung Transplant for Lung Cancer: Promising, in Rare Cases

In a small single-center study, 1-year survival is 100% among carefully selected patients who undergo bilateral lung transplantation for stage IV disease confined to the lungs.

Latest News

Persistent hyponatremia despite treatment prompts further evaluation, revealing isolated aldosterone deficiency despite normal adrenal function and leading to effective therapy.

Anxiety disorders are common but often missed in primary care, and routine screening, cognitive-behavioral therapy, and collaborative care may help GPs identify and manage them earlier.

Syphilis has reemerged as a major public health threat across Australia but signs indicate that things might be improving.

A connective tissue disorder with wide-ranging symptoms, hypermobile Ehlers-Danlos syndrome can lead to serious complications and harm from a medical system that doesn’t understand it.

An effort to produce recommendations for hospitalists to treat atrial fibrillation led to a wide-ranging search for answers.

More hospitals and EMS systems are stocking blood to begin transfusions in trauma patients. Many believe it is saving lives.

News All Time

Cancer Recurrence: What Awakens Dormant Tumor Cells?

Emerging therapies target dormant tumor cells and their microenvironment to delay or prevent metastatic recurrence after successful cancer treatment.

Autoimmune Diseases Respond to Teclistamab but With Risks

Teclistamab may have potential for clinical responses in patients with refractory autoimmune diseases; however, cytokine release syndrome and infections occur frequently.

Expanded Pediatric Use for Roflumilast Under FDA Review

If approved, topical roflumilast 0.05% will be approved for treating atopic dermatitis down to age 3 months.

Model Spots Kids With Anaphylaxis Who Do Not Require ED Care

A prediction model identifies children with anaphylaxis who are at a low risk of requiring additional epinephrine and may safely avoid visits to the emergency department.

What's Really Killing Patients With Late-Stage PD?

A decade-long study finds aspiration pneumonia as the leading cause of death in late-stage Parkinson's disease, and worsening motor function, cognition, and depression predict a higher risk for death.

Lower Breathing Pressure Tied to Complications in Preemies

In premature babies, lower breathing pressure at birth is linked to a higher likelihood of needing a breathing tube and later lung and eye complications.

Inside Isolation Units for Highly Contagious Diseases

The Spanish model highlights the infrastructure, training, and containment measures required for high-risk infectious disease care.

Education Nudges Patients With CKD Away From Haemodialysis

Structured predialysis education may help patients with chronic kidney disease stages 4 and 5 to choose peritoneal dialysis over haemodialysis, a Polish study finds.

Trump CDC Nominee Schwartz Set for July 15 US Senate Confirmation Hearing

Erica Schwartz, President Donald Trump's nominee to lead the U.S. Centers for Disease Control and Prevention, will appear before the Senate Committee on Health, Education,...

The Essential Clinical Research You’re Probably Not Reading

Qualitative research has long been viewed as less rigorous and less important — but that’s changing. Here’s where to find the highest-quality studies and how to use them to help your patients.

Uveitis Patterns Vary in Relation to Spondyloarthritis Type

Patients with peripheral forms of spondyloarthritis show a higher prevalence of different uveitis patterns than those with axial forms.

Children With Sesame Allergy Often Tolerate Intact Seeds

Most children with sesame allergy who develop reactions to concentrated sesame products tolerate whole seeds during supervised oral food challenge, supporting individualized dietary counseling.

Pernicious Anemia: How a Fatal Disease Became Treatable

Once nearly always fatal, pernicious anemia became treatable through a series of discoveries linking the stomach, liver, and ultimately vitamin B12.

AI Is Making Uneven Inroads in Pulmonary Medicine

AI tools are proliferating across pulmonary medicine and critical care, with promising early results in diagnostics and prediction, but significant gaps between development and deployment.

Pain Persists Despite Low Inflammation in Many With Early RA

Patients newly diagnosed with rheumatoid arthritis often experience unacceptable pain at 2 years despite having low levels of inflammation, a study finds.

Can CRISPR Make CAR T Safer and More Scalable?

Combining CRISPR/Cas9 with CAR T aims to let patients’ T cells be reprogrammed in vivo, potentially lowering cost and expanding use to solid tumors and autoimmune disease.

Recommended News For You

Medical debt in collections persists after cancer diagnosis

Early, virtual palliative care feasible for advanced lung cancer

Year in Review: Chronic Lymphocytic Leukemia

Psychiatric Disorders Are Common in Dementia Patients.

Remote monitoring can improve recovery from cancer surgery

Researchers discover cellular 'doorway' exploited by cancer-causing virus

Abemaciclib Slows Progression of Advanced Liposarcoma

Recommended Articles For You

Checkpoint Inhibitors in Oncology: Advances in PD-1/PD-L1 and CTLA-4 Targeted Therapy 

Mechanistic Insights into Abraxane, Verzenio, and the Management of Chemotherapy-Induced Tachycardia 

Tumor Microenvironment Targeting: Mechanisms, Clinical Implications, and Therapeutic Advances 

Advanced Directions in Oncology and Quality Improvement 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Research Indicates that First-Line Immunotherapy Is Enough for Elderly NSCLC Patients?

2.

FDA Greenlights First Engineered Cell Therapy for a Solid Tumor

3.

Pivotal Studies in Double-Expressor DLBCL Yield Divergent Results

4.

Oncology Drug Shortages Persist, but Continue to Evolve

5.

Are patients with advanced cancer receiving treatment aligned with their goals?

1.

Unveiling Tumor Immunity: Pan-Cancer Proteogenomics Characterization

2.

Hematopoietic Aging Signatures and Future Hematologic Disease Risk

3.

Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025

4.

Clinical Frameworks in Oncology and Quality Improvement

5.

Unlocking the Power of Neutrophils: Harnessing Their Disease-Fighting Potential

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

An Intro to The Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer Clinical Studies.

2.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III

3.

Efficient Management of First line ALK-rearranged NSCLC - Part II

4.

Current Scenario of Cancer- Final Discussion on the Importance of Genomic Testing & Advancement in Diagnosis and Treatment

5.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot